AT317229B - Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen - Google Patents
Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinenInfo
- Publication number
- AT317229B AT317229B AT605473A AT605473A AT317229B AT 317229 B AT317229 B AT 317229B AT 605473 A AT605473 A AT 605473A AT 605473 A AT605473 A AT 605473A AT 317229 B AT317229 B AT 317229B
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- hydroxy
- new
- production
- pyrimidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7821670A | 1970-10-05 | 1970-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT317229B true AT317229B (de) | 1974-08-26 |
Family
ID=22142671
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00148/73A AT315856B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen |
| AT00149/73A AT316563B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen |
| AT605473A AT317229B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen |
| AT858071A AT314540B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00148/73A AT315856B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen |
| AT00149/73A AT316563B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT858071A AT314540B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3707560A (de) |
| JP (2) | JPS5648511B1 (de) |
| AT (4) | AT315856B (de) |
| AU (1) | AU465734B2 (de) |
| BE (1) | BE773484A (de) |
| CA (1) | CA988519A (de) |
| CH (4) | CH542218A (de) |
| DE (2) | DE2149249C3 (de) |
| DK (1) | DK131858C (de) |
| ES (4) | ES395676A1 (de) |
| FI (1) | FI55502C (de) |
| FR (1) | FR2110227B1 (de) |
| GB (2) | GB1373535A (de) |
| NL (1) | NL168511C (de) |
| SE (2) | SE385885B (de) |
| ZA (1) | ZA716615B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3859288A (en) * | 1970-10-05 | 1975-01-07 | Pfizer | Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators |
| US3908012A (en) * | 1970-10-05 | 1975-09-23 | Pfizer | Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators |
| US3895112A (en) * | 1970-10-05 | 1975-07-15 | Pfizer | Arylpyrimidines in the relaxation of smooth muscle |
| US3835132A (en) * | 1972-02-01 | 1974-09-10 | Shell Oil Co | Morpholino-piperazinyl pyrimidines |
| US3950525A (en) * | 1973-06-19 | 1976-04-13 | Pfizer Inc. | Relaxation of smooth muscle in a mammal |
| DE2343419A1 (de) * | 1973-08-29 | 1975-03-13 | Gruenenthal Chemie | Verfahren zur herstellung von pyrimidinderivaten |
| US4725600A (en) * | 1984-07-13 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent |
| JPH0625157B2 (ja) * | 1988-01-29 | 1994-04-06 | 宇部興産株式会社 | ４―ヒドロキシピリミジン類の製造方法 |
| US4935516A (en) * | 1988-01-29 | 1990-06-19 | Ube Industries, Ltd. | Process for preparing 4-hydroxypyrimidine |
| DE3825647A1 (de) * | 1988-07-28 | 1990-02-01 | Geyer Gmbh & Co Christian | Vorrichtung zur befestigung eines elektrischen schaltgeraetes |
| DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| EP1196411B1 (de) * | 1999-07-15 | 2003-09-17 | Pharmacopeia, Inc. | Bradikinin b1 rezeptor antagonisten |
| EP1484971B1 (de) * | 2002-03-15 | 2007-07-04 | Ciba SC Holding AG | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen |
| ATE493987T1 (de) * | 2002-05-22 | 2011-01-15 | Amgen Inc | Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen |
| MXPA05010496A (es) * | 2003-03-28 | 2005-11-16 | Pharmacia & Upjohn Co Llc | Moduladores alostericos positivos del receptor de acetilcolina nicotinico. |
| EP1877400A1 (de) * | 2005-04-15 | 2008-01-16 | Amgen, Inc | Vanilloidrezeptorliganden und deren verwendung bei behandlungen |
| JP2009164373A (ja) * | 2008-01-08 | 2009-07-23 | Toshiba Corp | 半導体装置 |
| WO2011091153A1 (en) * | 2010-01-25 | 2011-07-28 | Chdi, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| EA027451B1 (ru) | 2011-08-30 | 2017-07-31 | Схди Фаундейшн, Инк. | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и их применение |
| SG2014011654A (en) | 2011-08-30 | 2014-08-28 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| CN114588157A (zh) | 2014-07-17 | 2022-06-07 | Chdi基金会股份有限公司 | 用于治疗hiv相关病症的方法和组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3047462A (en) * | 1959-03-06 | 1962-07-31 | Lab Jacques Logeais Soc D Expl | Quinazolone anti-inflammatory composition |
-
1970
- 1970-10-05 US US78216A patent/US3707560A/en not_active Expired - Lifetime
-
1971
- 1971-09-30 FI FI2734/71A patent/FI55502C/fi active
- 1971-10-01 DK DK480171A patent/DK131858C/da not_active IP Right Cessation
- 1971-10-02 DE DE2149249A patent/DE2149249C3/de not_active Expired
- 1971-10-02 DE DE2165962A patent/DE2165962C2/de not_active Expired
- 1971-10-04 CA CA124,312A patent/CA988519A/en not_active Expired
- 1971-10-04 SE SE7112534-8A patent/SE385885B/xx unknown
- 1971-10-04 ZA ZA716615A patent/ZA716615B/xx unknown
- 1971-10-04 GB GB4615871A patent/GB1373535A/en not_active Expired
- 1971-10-04 SE SE7410488A patent/SE390304B/xx unknown
- 1971-10-04 GB GB3831673A patent/GB1373536A/en not_active Expired
- 1971-10-04 ES ES395676A patent/ES395676A1/es not_active Expired
- 1971-10-05 AT AT00148/73A patent/AT315856B/de not_active IP Right Cessation
- 1971-10-05 CH CH772973A patent/CH542218A/fr not_active IP Right Cessation
- 1971-10-05 CH CH1452971A patent/CH554876A/fr not_active IP Right Cessation
- 1971-10-05 AT AT00149/73A patent/AT316563B/de not_active IP Right Cessation
- 1971-10-05 AT AT605473A patent/AT317229B/de not_active IP Right Cessation
- 1971-10-05 CH CH1521472A patent/CH554875A/fr not_active IP Right Cessation
- 1971-10-05 JP JP7823771A patent/JPS5648511B1/ja active Pending
- 1971-10-05 CH CH1532172A patent/CH554346A/fr not_active IP Right Cessation
- 1971-10-05 AT AT858071A patent/AT314540B/de not_active IP Right Cessation
- 1971-10-05 FR FR7135815A patent/FR2110227B1/fr not_active Expired
- 1971-10-05 NL NLAANVRAGE7113670,A patent/NL168511C/xx not_active IP Right Cessation
- 1971-10-05 BE BE773484A patent/BE773484A/xx not_active IP Right Cessation
- 1971-10-06 AU AU34259/71A patent/AU465734B2/en not_active Expired
-
1973
- 1973-11-02 ES ES420210A patent/ES420210A1/es not_active Expired
- 1973-11-02 ES ES420211A patent/ES420211A1/es not_active Expired
- 1973-11-02 ES ES420209A patent/ES420209A1/es not_active Expired
-
1980
- 1980-08-11 JP JP11016380A patent/JPS5636468A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT311557B (de) | Verfahren zur Herstellung von neuen α-Aminopenicillinen | |
| AT317229B (de) | Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen | |
| CH525207A (de) | Verfahren zur Herstellung von neuen Riechstoffen | |
| CH550133A (de) | Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat. | |
| CH533072A (de) | Verfahren zur Herstellung von neuen Riechstoffen | |
| CH550214A (de) | Verfahren zur herstellung von cyclocopolymerisaten. | |
| CH547820A (de) | Verfahren zur herstellung von neuen 5-nitrofurylderivaten. | |
| CH547767A (de) | Verfahren zur herstellung von neuen riechstoffen. | |
| CH549567A (de) | Verfahren zur herstellung von 8-cyano-5-octanolid. | |
| CH547775A (de) | Verfahren zur herstellung von diaethylaminopropionaniliden. | |
| CH558800A (de) | Verfahren zur herstellung von chinazolinonen. | |
| CH557830A (de) | Verfahren zur herstellung von 1-aminosiochinolinen. | |
| CH542166A (de) | Verfahren zur Herstellung von neuen Riechstoffen | |
| CH557796A (de) | Verfahren zur herstellung von cyclopropylmethylalkylaminen. | |
| AT300775B (de) | Verfahren zur Herstellung von neuen halogenierten Benzylphenole | |
| CH548351A (de) | Verfahren zur herstellung von 3-alkyl-5-tert.-butylphenolen. | |
| CH557370A (de) | Verfahren zur herstellung von isoxazolylaethyl-tetrahydropyranolen. | |
| AT309705B (de) | Verfahren zur Herstellung von neuen 21-Floursteroiden | |
| AT310958B (de) | Verfahren zur Herstellung von neuen Octadecapeptiden | |
| CH557801A (de) | Verfahren zur herstellung von 1,1,3-trialkoxy-2-cyanopropanen. | |
| CH549582A (de) | Verfahren zur herstellung von neuen tetrahydro-benzodiazepinonen. | |
| AT310177B (de) | Verfahren zur Herstellung von neuen Chinazolinonen | |
| AT313497B (de) | Verfahren zur herstellung von neuen 16-methylen-9beta,10 alpha-steroiden | |
| CH547287A (de) | Verfahren zur herstellung von 5-formamidino-pyrazol-4aldehyden. | |
| AT300834B (de) | Verfahren zur Herstellung von neuen Cyclophosphaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |